The Journal of Supportive Oncology
The Journal of Supportive Oncology is a peer-reviewed medical journal whose major purpose is the publicationof review and original research articles that focus on the pathophysiology of cancer-related symptoms or laboratory research that may have therapeutic implications for improvement in patient quality of life and quality of survival. Topics cover all areas of supportive oncology, including symptoms and side effects of cancer therapy, quality of life, and palliative medicine. Abstracts
and proceedings from the Chicago Supportive Oncology. Conference will be published in JSO.
Conor Lynch, Editorial Director
The Journal of Supportive Oncology
Elsevier Oncology
Conor Lynch joined Elsevier Oncology (formerly BioLink Communications, Inc.) in 2003 and also serves as the Managing Editor for The Journal of Supportive Oncology and the Chicago Supportive Oncology Conference. He holds a Bachelor of Arts degree in English Literature from Georgetown University.
Community Oncology
Community Oncology features articles relating to research, quality of care, and practice management issues in the community setting. The content of the journal has broad relevance to the clinical problems faced by the practicing oncologist. Community Oncology is sent to over 31,000physicians, physician assistants, nurse practitioners, nurses, pharmacists and administrators in oncology; and is quickly becoming a clinical and economic forum/resource for the practicing oncologist.
Randi Londer Gould, Managing Editor
Community Oncology
Elsevier Oncology
Randi Londer Gould began her 30-year career as a freelance magazine writer specializing in health and science. She went on to co-author six books on topics ranging from climate change to diabetes and cancer genetics. Before joining Elsevier Oncology in 2004, Randi oversaw the development of and edited InTouch, a magazine for cancer patients. She earned her Master’s degree in journalism from Columbia University
The Oncology Report
The Oncology Report features comprehensive reports on the latest advances in cancer treatment presented at major oncology meetings with expert commentaries and analysis from renowned thought-leaders. The Oncology Report is designed with an attractive, easy-to-read format organized by tumor site. Each chapter features a topic index and reference to the meetings covered. TOR is sent free of charge to over 27,000 physicians, nurses, pharmacists and administrators.
|